Adjunctive therapy to diet for the reduction of elevated total-C, LDL-C, Apo B, TG & non-HDL-C, & to increase HDL-C in primary (heterozygous familial & non-familial) hypercholesterolemia or mixed hyperlipidemia. Reduction of elevated total-C & LDL-C levels in homozygous familial hypercholesterolemia.
Dose range: 10/10-10/40 mg/day. Usual starting dose: 10/20 mg/day. Initiation of therapy w/ 10/10 mg/day may be considered for patients requiring less aggressive LDL-C reductions.
C10BA02 - simvastatin and ezetimibe ; Belongs to the class of HMG CoA reductase inhibitors in combination with other lipid modifying agents. Used in the treatment of hyperlipidemia.
Sign Out
